Kangstem Biotech Co. Ltd Cash Flow Quality Index
Latest as of June 2024:
-0.50x
Kangstem Biotech Co. Ltd cash flow quality index. Kangstem Biotech Co. Ltd (217730) has a Cash Flow Quality Index of -0.50x as of June 2024. Operating cash flow of ₩-2.37 Billion is below net income of ₩4.71 Billion, suggesting accrual-heavy earnings not yet converted to cash. See how financially flexible is Kangstem Biotech Co. Ltd to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-0.50x
Operating CF / Net Income
Operating Cash Flow
₩-2.37 Billion
KRW
Net Income
₩4.71 Billion
KRW
Data as of
Jun 2024
Most recent filing
Kangstem Biotech Co. Ltd Cash Flow Quality Index by Year (None–None)
Kangstem Biotech Co. Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Kangstem Biotech Co. Ltd. For the full cash flow conversion analysis, see 217730 cash generation efficiency.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.